Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohortShailja Shah, Alese Halvorson, Brandon McBay, Chad Dorn, Otis Wilson, Sony Tuteja, Kyong-Mi Chang, Kelly Cho, Richard Hauger, Ayako Suzuki, Christine Hunt, Edward Siew, Michael Matheny, Adriana Hung, Robert GreevySee the full list of authors
18 October 2021
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemicSimeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
27 April 2022
Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actionsNicolas Chapelle, Myriam Martel, Alan N Barkun, Marc Bardou
2 April 2021
Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort studyGilaad G Kaplan, Christopher Ma, Carmen Charlton, Jamil N Kanji, Graham Tipples, Nastaran Sharifi, Michelle Herauf, Stephanie Coward, Richard J M Ingram, Lindsay Hracs, Eric I Benchimol, Remo Panaccione
2 August 2021
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse eventsSiew C Ng, Ye Peng, Lin Zhang, Chris KP Mok, Shilin Zhao, Amy Li, Jessica YL Ching, Yingzhi Liu, Shuai Yan, Dream L S Chan, Jie Zhu, Chunke Chen, Adrian CH Fung, Kenneth KY Wong, David SC HuiSee the full list of authors
9 February 2022
Comparison between non-pulmonary and pulmonary immune responses in a HIV decedent who succumbed to COVID-19Denise Goh, Justina Nadia Lee, Tracy Tien, Jeffrey Chun Tatt Lim, Sherlly Lim, An Sen Tan, Jin Liu, Benedict Tan, Joe Yeong
10 August 2021
Identification of the source events for aerosol generation during oesophago-gastro-duodenoscopyFlorence K A Gregson, Andrew J Shrimpton, Fergus Hamilton, Tim M Cook, Jonathan P Reid, Anthony E Pickering, Dimitri J Pournaras, Bryan R Bzdek, Jules Brown, , the AERATOR group, D Arnold, J Brown, B Bzdek, A DavidsonSee the full list of authors
29 June 2021
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, Richard J Dima, Nicole Jordan-Martin, Breanna R Demestichas, Sam O Kleeman, Miriam Ferrer, Eva Carlotta von Gablenz, Nicholas Mourikis, Michael E Rubin, Harsha Adnani, Hassal Lee, Taehoon Ha, Soma PrumSee the full list of authors
10 February 2022
Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?Esra Görgülü, Wenyi Gu, Jonel Trebicka, Victoria Therese Mücke, Marcus Maximilian Muecke, Mireen Friedrich-Rust, Joerg Bojunga, Stefan Zeuzem, Fabian Finkelmeier, Kai-Henrik Peiffer
17 June 2021
Humoral response to SARS-CoV-2 infection among liver transplant recipientsChiara Becchetti, Annelotte G C Broekhoven, Géraldine Dahlqvist, Montserrat Fraga, Marco Fabrizio Zambelli, Olga Ciccarelli, Anne-Catherine Saouli, Arianna Trizzino, Vanessa Banz, Jean-François Dufour, Anna H E Roukens, Shessy P Torres Morales, Sebenzile K Myeni, Marjolein Kikkert, Mariet C W FeltkampSee the full list of authors
5 January 2022
